Literature DB >> 10022418

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study.

E Barrett-Connor1, D G Von Mühlen, D Kritz-Silverstein.   

Abstract

A cross-sectional population-based study examined the association between endogenous sex hormones and depressed mood in community-dwelling older men. Participants included 856 men, ages 50-89 yr, who attended a clinic visit between 1984-87. Total and bioavailable testosterone, total and bioavailable estradiol, and dihydrotestosterone levels were measured by radioimmunoassay in an endocrinology research laboratory. Depressed mood was assessed with the Beck Depression Inventory (BDI). Levels of bioavailable testosterone and bioavailable estradiol decreased with age, but total testosterone, dihydrotestosterone, and total estradiol did not. BDI scores increased with age. Low bioavailable testosterone levels and high BDI scores were associated with weight loss and lack of physical activity, but not with cigarette smoking or alcohol intake. By linear regression or quartile analysis the BDI score was significantly and inversely associated with bioavailable testosterone (both Ps = 0.007), independent of age, weight change, and physical activity; similar associations were seen for dihydrotestosterone (P = 0.048 and P = 0.09, respectively). Bioavailable testosterone levels were 17% lower for the 25 men with categorically defined depression than levels observed in all other men (P = 0.01). Neither total nor bioavailable estradiol was associated with depressed mood. These results suggest that testosterone treatment might improve depressed mood in older men who have low levels of bioavailable testosterone. A clinical trial is necessary to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022418     DOI: 10.1210/jcem.84.2.5495

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  75 in total

1.  For and against: The male menopause--does it exist?

Authors:  D C Gould; R Petty; H S Jacobs
Journal:  BMJ       Date:  2000-03-25

2.  The male menopause: does it exist?: for: some men need investigation and testosterone treatment

Authors: 
Journal:  West J Med       Date:  2000-08

Review 3.  Sexual dysfunction and depression.

Authors:  S N Seidman; S P Roose
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 4.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 5.  Andropause: to treat or not to treat?

Authors:  S Basaria; A Dobs
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 6.  Effects of androgen replacement on metabolism and physical performances in male hypogonadism.

Authors:  M Zitzmann; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 7.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

8.  Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis.

Authors:  Baris Afsar
Journal:  Clin Exp Nephrol       Date:  2012-06-22       Impact factor: 2.801

Review 9.  Depression in aging men: the role of testosterone.

Authors:  Ryan M Carnahan; Paul J Perry
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women.

Authors:  A Walther; C Tsao; R Pande; C Kirschbaum; E Field; L Berkman
Journal:  Psychoneuroendocrinology       Date:  2019-07-19       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.